BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6104603)

  • 1. Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?
    Costall B; Fortune DH; Hui SC; Naylor RJ
    Eur J Pharmacol; 1980 May; 63(4):347-58. PubMed ID: 6104603
    [No Abstract]   [Full Text] [Related]  

  • 2. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH; Roberts DC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of apomorphine administered into the accumbens in rats with bilateral lesions of the nucleus accumbens, induced with 6-hydroxydopamine.
    Radhakishun FS; Wolterink G; van Ree JM
    Neuropharmacology; 1988 Nov; 27(11):1111-6. PubMed ID: 3144656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.
    Kafetzopoulos E
    Psychopharmacology (Berl); 1986; 88(3):271-4. PubMed ID: 3083447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity.
    Van Ree JM; Wolterink G
    Eur J Pharmacol; 1981 Jun; 72(1):107-11. PubMed ID: 7262189
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic interaction with the serotoninergic-dopaminergic mechanisms in the nucleus accumbens.
    Costall B; Naylor RJ
    J Pharm Pharmacol; 1978 Apr; 30(4):257-9. PubMed ID: 24720
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 10. Muscimol a GABA-agonist injected into the nucleus accumbens increases apomorphine stereotypy and decreases the motility.
    Scheel-Krũger J; Cools AR; van Wel PM
    Life Sci; 1977 Dec; 21(11):1697-702. PubMed ID: 563960
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A demonstration of the ability of apomorphine to act on dopamine receptors on nerve terminals in the nucleus accumbens to reduce locomotor hyperactivity [proceedings].
    Costall B; Hui SC; Naylor RJ
    Br J Pharmacol; 1979 Nov; 67(3):475P-476P. PubMed ID: 497587
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of SCH23390 injection into the dorsal striatum and nucleus accumbens on methamphetamine-induced gnawing and hyperlocomotion in rats.
    Koshikawa N; Mori E; Oka K; Nomura H; Yatsushige N; Maruyama Y
    J Nihon Univ Sch Dent; 1989 Jun; 31(2):451-7. PubMed ID: 2570826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniquely, gamma-endorphin induces an effect that is both opiate- and neuroleptic-like.
    van Ree JM; Gaffori O
    Life Sci; 1983; 33 Suppl 1():619-22. PubMed ID: 6198576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circling behavior produced by the unilateral intra-accumbens injection of dopaminergic agonist and two dopaminergic antagonists in mice].
    Mrabet O; Messier C; Destrade C
    C R Acad Sci III; 1989; 309(3):77-82. PubMed ID: 2504444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R; Cools AR; Ogren SO
    Acta Physiol Scand; 1990 Mar; 138(3):423-4. PubMed ID: 2158210
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R; Cools AR; Ogren SO
    Acta Physiol Scand; 1989 Dec; 137(4):547-8. PubMed ID: 2557730
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens.
    Morgenstern R; Fink H
    Biomed Biochim Acta; 1985; 44(10):1517-22. PubMed ID: 4084255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens.
    Roberts DC
    Pharmacol Biochem Behav; 1989 Jan; 32(1):43-7. PubMed ID: 2499893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.